ANDA 72514, held by Aurolife Pharma LLC. Clorazepate Dipotassium.
As of Nov 16, 2026, ANDA 72514 (Clorazepate Dipotassium), held by Aurolife Pharma LLC, was first approved by FDA on May 11, 1990, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 11, 1990 | Original application | Approved | None posted |
| Clorazepate Dipotassium15MG · tablet;oral | Clorazepate Dipotassium | Discontinued |
| Clorazepate Dipotassium3.75MG · tablet;oral | Clorazepate Dipotassium | Discontinued |
| Clorazepate Dipotassium7.5MG · tablet;oral | Clorazepate Dipotassium | Discontinued |
| Jan 10, 2000 | Supplement 2Manufacturing | Approved | None posted |
| Jan 24, 1994 | Supplement 1Manufacturing | Approved | None posted |
| May 11, 1990 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters